CD4 and COVID-19: In agreement with prior evidence linking short leukocyte telomeres to poor COVID-19 outcomes [1], our data implicate CD4+ T cell aging as a predominant driver for immunopathology in patients with advanced ages where additional age-related immune remodeling may have been plateaued.